mTOR Inhibitors
- Name
- mTOR Inhibitors
- Accession Number
- DBCAT004158
- Description
Medications that exert their immunosuppressive effects via inhibition of the mammalian target of rapamycin (mTOR)
- Drugs
Drug Drug Description Everolimus A mammalian target of rapamycin (mTOR) kinase inhibitor used to treat various types of malignancies. Sirolimus An mTOR inhibitor immunosuppressant used to prevent organ transplant rejections, treat lymphangioleiomyomatosis, and treat adults with perivascular epithelioid cell tumors. Temsirolimus A antineoplastic agent used in the treatment of renal cell carcinoma (RCC) that works by inhibiting mTOR. - Drugs & Drug Targets